Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

99859

registered interest
date	20/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prescription Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if his Department will commission a review of the innovation, evaluation and adoption of new medicines in the NHS; and if he will make a statement.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	211101
answer	answer is ministerial correction date of answer 23/10/2014 answer text <p>We are committed to ensuring National Health Service patients have access to effective medicines on terms that represent value to the NHS and taxpayers and that patients, are supported to get the best outcomes from their medicines.</p><p> </p><p> </p><p> </p><p>The Department, in collaboration with NHS England, has recently commissioned an independent evaluation of Innovation Health and Wealth. Jointly led by the University of Manchester and RAND Europe, The first initial phase is now underway, the study is expected to take three years to complete.</p><p> </p><p><em> </em></p><p> </p><p>In addition, NHS England, with the Health and Social Care Information Centre publishes an innovation scorecard which represents the rate of uptake and utility of medicines in both primary and secondary care, on a regular basis. This publication sets out levels of uptake and utility for National Institute for Health and Care Excellence appraised medicines and technologies, and evidence suggests that steady growth is being achieved and the most recent information is available at:</p><p> </p><p> </p><p> </p><p><a href="http://www.hscic.gov.uk/searchcatalogue?productid=15598&amp;q=innovation+scorecard&amp;sort=Relevance&amp;size=10&amp;page=1#top" target="_blank">www.hscic.gov.uk/searchcatalogue?productid=15598&amp;q=innovation+scorecard&amp;sort=Relevance&amp;size=10&amp;page=1#top</a></p><p> </p><p><strong> </strong></p><p> </p><p>Earlier this year, NHS England also undertook an extensive consultation to ‘refresh’ the Innovation Health and Wealth policy framework and we understand that recommendations from this will be included in NHS England's five year Forward Look.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 23/10/2014 16:35:13 answering member 4020 label Biography information for George Freeman
tabling member	4056 label Biography information for Nic Dakin

99860

registered interest
date	20/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Social Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when his Department will publish a response to the consultation Updating our care and support system: draft regulations and guidance, published on 6 June 2014.
tabling member constituency	South Shields
tabling member printed	Mrs Emma Lewell-Buck
uin	211058
answer	answer is ministerial correction date of answer 23/10/2014 answer text <p>A consultation on the draft regulations and guidance to support implementation of part one of the Care Act 2014 opened on 5 June 2014 and ran for 10 weeks to 15 August 2014.</p><p> </p><p> </p><p> </p><p>The Government will publish a response to the consultation shortly. The statutory guidance to support implementation of part one of the Care Act will be published at the same time.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 23/10/2014 11:36:29 answering member 1439 label Biography information for Norman Lamb
tabling member	4277 label Biography information for Mrs Emma Lewell-Buck

99865

registered interest
date	20/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mental Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the average waiting time is for treatment by adult mental health services for people who have suffered sexual abuse.
tabling member constituency	Warrington North
tabling member printed	Helen Jones
uin	211022
answer	answer is ministerial correction date of answer 23/10/2014 answer text <p>The information is not collected centrally. Earlier this month the Department published <em>Achieving Better Access to Mental Health Services by 2020</em>, which articulates our ambition and the immediate actions we will take this year and next to achieve better access and waiting times for mental health services for all patients.</p><p> </p><p> </p><p> </p><p>We have identified £40 million additional spending to kick start change in the current year and a further £80 million to be freed up for 2015-16. This will, for the first time ever, enable the setting of access and waiting time standards in mental health services.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 23/10/2014 11:11:12 answering member 1439 label Biography information for Norman Lamb
tabling member	432 label Biography information for Helen Jones

99869

registered interest
date	20/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what his future policy towards the National Cancer Peer Review programme is.
tabling member constituency	Mid Dorset and North Poole
tabling member printed	Annette Brooke
uin	211052
answer	answer is ministerial correction date of answer 23/10/2014 answer text <p>NHS England is currently reviewing the National Cancer Peer Review programme with a view to considering how its success might be extended into other new areas of specialised commissioning. Regardless of the outcome of this review, cancer peer review will continue to play a critical part of any broader peer review programme that the NHS may look to introduce.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 23/10/2014 15:42:50 answering member 3918 label Biography information for Jane Ellison
tabling member	1431 label Biography information for Annette Brooke

99875

registered interest
date	20/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	General Dental Council
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what recent representations his Department has received on the General Dental Council's annual retention fee.
tabling member constituency	Mid Dorset and North Poole
tabling member printed	Annette Brooke
uin	211166
answer	answer is ministerial correction date of answer 23/10/2014 answer text <p>Since 1 July 2014, the Department has received a number of representations regarding the General Dental Council’s (GDC) proposed increase to the annual retention fee. As at 22 October 2014, these representations included seven items of correspondence: one from the Chair of the GDC, one from the British Dental Association and five from Members of Parliament. The Department has received three related Parliamentary Questions and has responded to an e-petition opposing an increase in the GDC’s annual retention fee.</p><p> </p><p> </p><p> </p><p>On 3 September 2014, I met with the GDC where, amongst other things, concerns about the proposal fee rise were discussed.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 23/10/2014 11:30:41 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	1431 label Biography information for Annette Brooke

99876

registered interest
date	20/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hearing Impairment: Babies
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he has taken in respect of paediatric audiology services which do not meet the standards set out in the quality assurance newborn hearing screening programme.
tabling member constituency	Mid Dorset and North Poole
tabling member printed	Annette Brooke
uin	211168
answer	answer is ministerial correction date of answer 23/10/2014 answer text <p>Between September 2012 and March 2013 the NHS Newborn Hearing Screening Programme (NHSP) provided each individual hearing screening programme with an individual detailed quality assurance (QA) report and action plan. These QA reports are available directly from the screening programmes or via the NHSP website at</p><p> </p><p> </p><p> </p><p><a href="http://hearing.screening.nhs.uk/qualityassurance" target="_blank">http://hearing.screening.nhs.uk/qualityassurance</a></p><p> </p><p> </p><p> </p><p>It is up to local NHS paediatric services as to how they implement these action plans.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 23/10/2014 15:34:21 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	1431 label Biography information for Annette Brooke

99878

registered interest
date	20/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hepatitis: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much his Department spent on medicines for hepatitis C treatment in each of the last three financial years.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	211146
answer	answer is ministerial correction date of answer 23/10/2014 answer text <p>Information on spend by the National Health Service in primary and secondary care is in the table.</p><p> </p><p><strong> </strong></p><p> </p><p>Medicines for the treatment of hepatitis C have been defined as all medicines contained within British National Formulary section 5.3.3.4 - chronic hepatitis C. In addition, peginterferon alfa, ribavirin and interferon alfa have also been included as they have been recommended in National Institute for Health and Care excellence technology appraisals for use in treating hepatitis C.</p><p> </p><p> </p><p> </p><p>Since some drugs are prescribed to treat more than one condition, it may not be possible to separate the different conditions for which a drug may have been prescribed and therefore figures may include costs from prescriptions of these drugs other than for hepatitis C.</p><p> </p><p><strong> </strong></p><p> </p><p>This is the cost of the medicines at NHS list price and not necessarily the price paid. It does not take account of discounts, dispensing costs, fees or prescription charges income.</p><p> </p><p> </p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>Cost (£000)</p></td></tr><tr><td><p>2011-12</p></td><td><p>34,198.9</p></td></tr><tr><td><p>2012-13</p></td><td><p>52,709.2</p></td></tr><tr><td><p>2013-14</p></td><td><p>72,122.0</p></td></tr></tbody></table><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><em>Source: </em></p><p> </p><p>Prescription Cost Analysis (PCA) provided by the Health and Social Care Information Centre (primary care)</p><p> </p><p>Hospital Pharmacy Audit Index (HPAI) provided by IMS Health (secondary care)</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 23/10/2014 16:40:20 answering member 4020 label Biography information for George Freeman
tabling member	4036 label Biography information for Luciana Berger

99879

registered interest
date	20/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Liver Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what recent discussions officials in his Department have had with (a) Public Health England and (b) NHS England on the development of a liver strategy or liver framework; and if he will make a statement.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	211147
answer	answer is ministerial correction date of answer 23/10/2014 answer text <p>Public Health England (PHE) has a wide ranging programme designed to tackle the rising mortality and morbidity from liver disease. At each stage officials at the Department are in discussion with PHE.</p><p> </p><p> </p><p> </p><p>In response to the All Party Parliamentary Hepatology Group report PHE has committed to producing a Liver Disease Framework. This will focus on public health action to tackle risk factors for liver disease and inequalities in relation to liver disease. Work has already begun to bring together expertise within PHE on the major risk factors for liver disease (alcohol, hepatitis B and C and obesity), data on liver disease and its risk factors and on death and dying from liver disease. Many of the actions to tackle the major risk factors require a coordinated approach between PHE and NHS England.</p><p> </p><p> </p><p> </p><p>A meeting will be held on 25 November between PHE officials, NHS England officials, Departmental officials and representatives of Charities to outline the emerging framework and to seek comment and advice. The Lead for Liver Disease at PHE is working closely with the National Clinical Director for Gastroenterology. The Department is kept informed of PHE’s work programme on liver disease through discussion and communication.</p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 23/10/2014 15:27:46 answering member 3918 label Biography information for Jane Ellison
tabling member	4036 label Biography information for Luciana Berger

99880

registered interest
date	20/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pregnancy: Mental Illness
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many women in the perinatal period have (a) attempted suicide and (b) taken their own lives in each of the last four years.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	211148
answer	answer is ministerial correction date of answer 23/10/2014 answer text <p>This information is not collected centrally.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 23/10/2014 15:13:42 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	4036 label Biography information for Luciana Berger

99881

registered interest
date	20/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Dialysis Machines
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, for what reasons his Department has proposed a reduction in tariffs for kidney dialysis.
tabling member constituency	Barnsley Central
tabling member printed	Dan Jarvis
uin	211193
answer	answer is ministerial correction date of answer 23/10/2014 answer text <p>Monitor and NHS England published the National tariff Payment System Engagement Documents on 15 July, which also included indicative draft prices for 2015-16. While some draft prices proposed for 2015-16 were higher than the previous year, there were also reductions in prices. Following consultation with commissioners, providers, clinicians and service users, the best practice tariff for renal care is being reviewed. Final prices will be published alongside the 2015-16 National tariff Payment System Consultation Notice later this year.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 23/10/2014 15:40:06 answering member 3918 label Biography information for Jane Ellison
tabling member	4243 label Biography information for Dan Jarvis